Evolution Mining Up Over 150%: What Analyst Price Targets Reveal About Gold Mining Shares on the ASX

Evolution Mining shares have surged more than 150%, yet analyst price targets still sit below current levels. This article explains why targets lag strong gold prices, what EVN’s fundamentals reveal, and how investors should interpret the growing gap between analyst models and market reality.

Is Mesoblast a Buy After Its A$186M Refinancing? Here's What Investors Need to Know

Mesoblast has secured a A$186 million non-dilutive refinancing and is delivering strong Ryoncil revenue growth. This article breaks down what the deal means for cash flow, risk, and long-term upside, helping investors assess whether MSB is turning into a genuine commercial biotech opportunity.

ASX Dividend Yields at Multi-Year Lows: 6 Income Stocks to Watch

ASX yields are at multi-year lows. Review six income stocks with stronger yield support and learn how franking can change the real return.

Qube Holdings in Focus: Why This Midcap Transport Stock Is Trading Higher

Pilbara Minerals vs IGO vs Liontown: Macquarie Names Top Lithium Stocks to Buy and Avoid

Stay ahead of the lithium market recovery. Macquarie reveals which ASX producers are positioned to benefit from the sector rebound—and which stocks investors should avoid as volatility continues.

Core Lithium Jumps 80%: Buy, Sell or Hold After the Finniss Restart?

Core Lithium has surged 80% in a month, but Finniss remains idle and funding needs are high. Is this a genuine lithium recovery play or market hype? Read the full analysis to find out.